Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
+0,27%
1 096,71
+2,90
+0,27%
—1 093,811 096,521 100,221 093,20——
SIXC
Communications
SIXC
Communications
SIXC
+0,28%
610,47
+1,70
+0,28%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,28%
1 238,69
-16,12
-1,28%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,63%
1 750,10
-11,01
-0,63%
—1 761,111 764,271 766,881 745,39——
SIXM
Financials
SIXM
Financials
SIXM
-0,01%
642,49
-0,090
-0,01%
—642,58644,87648,48641,91——
SIXR
Staples
SIXR
Staples
SIXR
-0,51%
846,76
-4,37
-0,51%
—851,13855,66858,75845,93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,35%
217,22
-0,76
-0,35%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,61%
3 263,44
+51,61
+1,61%
—3 211,833 227,213 267,763 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,61%
943,17
-5,81
-0,61%
—948,98948,58957,83943,44——
SIXV
Health care
SIXV
Health care
SIXV
-0,24%
1 471,03
-3,49
-0,24%
—1 474,521 479,031 481,041 469,17——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,60%
2 406,54
+14,42
+0,60%
—2 392,122 396,952 421,222 382,32——
FLNA:NASDAQ
Filana Therapeutics Inc
1,54 US$
+6,55%
(+0,095) 1K
1-may, 14:45:55 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
FLNA tikeri uchun statistika yaratilmoqda...
Ochish
1,44 US$
Yuqori
1,58 US$
Past
1,44 US$
Bozor kapitali
74,88 mln
Oʻrtacha hajm
407,12 ming
Hajmi
626,28 ming
52 haftalik eng yuqori
2,27 US$
52 haftalik eng past
1,44 US$
Aksiya boʻyicha daromad
-1,88 US$
Beta
-0,66
Muomaladagi aksiyalar
48,31 mln
Xodimlar soni
19
Yangiliklar
Internetdagi manbalardan
Profil
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. The company was developing simufilam, an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials. In June 2024, the United States Department of Justice charged an advisor to company, Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. The DOJ dropped the fraud charges against Wang shortly before trial was scheduled to begin in October 2025 without giving a reason. Wikipedia
Filana Therapeutics Inc haqida
CEO-
Xodimlar soni19
Asos solingan1998
Bosh ofislarOstin, Texas, Amerika Qo‘shma Shtatlari
Sektor-
Veb-sayt-
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – USD
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
-
-
-
-
Sotilgan mahsulotning tannarxi
13,67 mln
5,12 mln
3,96 mln
3,85 mln
Daromad narxi
13,67 mln
5,12 mln
3,96 mln
3,85 mln
Tadqiqot va ishlanmalarga xarajatlar
-
-
-
-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
7,92 mln
8,98 mln
7,90 mln
5,70 mln
Operatsion xarajatlar
7,92 mln
8,98 mln
7,90 mln
5,70 mln
Jami operatsion xarajatlar
21,59 mln
14,09 mln
11,86 mln
9,55 mln
Operatsion daromad
-21,59 mln
-14,09 mln
-11,86 mln
-9,55 mln
Boshqa nooperatsion daromad
-82,00 ming
-46,00 ming
-114,00 ming
39,00 ming
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-23,40 mln
-44,22 mln
-10,81 mln
-12,54 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-20,40 mln
-12,92 mln
-10,81 mln
-8,54 mln
Daromad soligʻi boʻyicha xarajat
-
-
-
-
Amaldagi soliq stavkasi
-
-
-
-
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
-23,40 mln
-44,22 mln
-10,81 mln
-12,54 mln
Sof foyda marjasi
-
-
-
-
Har bir aksiya foydasi
-
-
-
-
Foizlar va investitsiyalardan olingan daromadlar
1,26 mln
1,21 mln
1,17 mln
974,00 ming
Foizlarni toʻlash xarajatlari
-
-
-
-
Foizlarni toʻlash boʻyicha sof xarajatlar
1,26 mln
1,21 mln
1,17 mln
974,00 ming
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
-21,37 mln
-13,87 mln
-11,73 mln
-9,18 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish